27.1. Analysis.
Comparison 27: Sensitivity analysis 7, excluding comparisons responsible for the high level of heterogeneity, Outcome 1: Number of fallers ‐ cholinesterase inhibitor vs placebo
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.